MPS Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

19.11

19.11

19.11

19.11

19.11

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

-17.14

-16.32

-15.29

-15.16

-10.75

Loan funds

Secured loans

7.27

6.76

5.81

1.93

2.54

Unsecured loans

-

-

-

-

-

Total

9.24

9.56

9.63

5.88

10.90

Uses of funds

Fixed assets

Gross block

15.86

15.84

15.72

15.71

16.05

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

11.84

11.70

11.55

11.04

10.79

Net block

4.01

4.14

4.17

4.68

5.26

Capital work-in-progress

3.26

3.40

3.42

3.90

5.02

Investments

0.54

0.54

0.54

0.54

0.92

Net current assets

Current assets, loans & advances

2.12

2.10

2.03

2.19

5.21

Less : current liabilities & provisions

0.69

0.63

0.53

5.42

5.51

Total net current assets

1.43

1.47

1.50

-3.23

-0.30

Miscellaneous expenses not written

-

-

-

-

-

Total

9.24

9.56

9.63

5.88

10.90

Notes:

Book value of unquoted investments

0.54

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

0.04

-

-

9.29

7.31

Number of equity sharesoutstanding (Lacs)

191.11

191.11

191.11

191.11

191.11